Structure of CD94 Reveals a Novel C-Type Lectin Fold
- 1 January 1999
- Vol. 10 (1) , 75-82
- https://doi.org/10.1016/s1074-7613(00)80008-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated LysisThe Journal of Experimental Medicine, 1998
- HLA-E binds to natural killer cell receptors CD94/NKG2A, B and CNature, 1998
- The activating form of CD94 receptor complex: CD94 covalently associated with the Kp39 protein that represents the product of the NKG2-C geneEuropean Journal of Immunology, 1998
- TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptideCurrent Biology, 1998
- The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9European Journal of Immunology, 1997
- NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell ReceptorThe Journal of Experimental Medicine, 1997
- The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I moleculesEuropean Journal of Immunology, 1997
- The C-type carbohydrate recognition domain (CRD) superfamilyBiochemical Society Transactions, 1994
- Ca2+-dependent carbohydrate-recognition domains in animal proteinsCurrent Opinion in Structural Biology, 1993
- Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the ComplexScience, 1992